| Table 5: The myocardial histopathological changes among different groups. |
| | Group | Dose (g·kg−1) | Early coagulation necrosis | Hyperemia bleeding | Inflammatory
cells infiltrating | | | − | + | ++ | +++ | − | + | ++ | +++ | − | + | ++ | +++ |
| | Control | — | 8 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | | Model | — | 0 | 1 | 6 | 1 | 0 | 0 | 7 | 1 | 0 | 4 | 4 | 0* | | DDP | 0.14 | 0 | 6 | 2 | 0 | 1 | 4 | 3 | 0 | 0 | 4 | 4 | 0# | | SDG | 0.70 | 0 | 1 | 7 | 0 | 0 | 2 | 5 | 1 | 0 | 4 | 4 | 0# | | MDG | 1.40 | 0 | 7 | 1 | 0 | 1 | 5 | 2 | 0 | 0 | 7 | 1 | 0# | | LDG | 2.80 | 2 | 5 | 1 | 0 | 0 | 6 | 2 | 0 | 2 | 6 | 0 | 0# |
|
|
Note: *, compared with the positive drug group; #, compared with the control group.
|